Introduction
Most adult patients with asthma respond to therapy with moderate doses of inhaled corticosteroids alone or in addition to a long-acting b 2 -agonist. Approximately 5% of adult patients remain difficultto-control despite high-dose inhaled steroids 1 and debate exists as to the next best therapeutic intervention, 2 but these patients are a cause of concern because of persistent symptoms and impairment of quality of life, continued impaired lung function, increased risk of asthma deaths and adverse effects of high-dose corticosteroids. 1, 3 It is likely that a number of factors contribute to the lack of adequate control in these subjects, and psychiatric disorder has been proposed as a modulator of difficult asthma. 1, 3, 4 A number of retrospective confidential enquiries into asthma death and case control studies in near-fatal asthma [5] [6] [7] have demonstrated an association with psychiatric morbidity and recent life events, though this has not been the case universally. 8, 9 Hospital admission with asthma is also associated with psychiatric morbidity though this does not appear to differ in those who present with a nearfatal attack 10 and more recently increased psychiatric morbidity has been shown to predict relapse after treatment for acute asthma. 11 In subjects with chronic persistent asthma, a number of studies, using screening questionnaires, have shown increased evidence of morbidity in asthmatic patients with evidence of increased anxiety, depression and poor coping skills. [12] [13] [14] In the Managed Care Outcomes Project 15 looking at optimal clinical outcomes using the Clinical Practice Improvement (CPI) model, depression accounted for the majority of psychiatric diagnoses. In this study, psychiatric illness was under-diagnosed and associated with more severe asthma, which has been suggested by other authors, 16 though this association between psychopathology and asthma severity has not been consistently present. 17 Ten Brinke has suggested that increased health service utilisation and thus costs are related to the level of psychological dysfunction in patients with difficult-to-control asthma. 18 In patients with asthma, symptom scores appeared to correlate better with degree of anxiety and depression than with lung function, suggesting it may be the interpretation of symptoms which is more relevant than the degree of physiological impairment. 16, 19 Brittle asthma, a particular sub-type of difficult-tocontrol asthma, is also associated with psychiatric morbidity. 20 Given the association between fatal/near-fatal asthma and psychiatric morbidity and the suggestion of increased psychiatric morbidity in subjects with chronic persistent asthma, we hypothesised that there would be a high prevalence of undiagnosed psychiatric morbidity in a difficult-to-control asthma population. We also hypothesised that when psychiatric illness was identified and appropriately managed, this would be associated with an improved asthma outcome. In addition, we wished to examine the relationship between formal psychiatric diagnostic interview and the Hospital Anxiety Depression Scale (HADS), 21 a commonly used screening tool for psychiatric morbidity, in patients attending hospital. To test these hypotheses, we performed formal psychiatric assessment and HADS questionnaire, as part of a systematic evaluation protocol, in a sequentially referred population of difficult-to-control asthmatics.
Methods
The details of the systematic evaluation protocol and management has been published elsewhere. 22 In brief, patients were recruited for protocol evaluation, if they had (1) persisting refractory symptoms prompting referral, (2) minimal maintenance therapy of long-acting b 2 -agonist and inhaled steroids (X800 mg BDP or equivalent) and (3) at least 1 course of systemic steroids in preceding 12 months. Asthma was defined on the basis of symptoms together with current or previously documented reversible airflow obstruction (forced expiratory volume at 1 s of 412% either spontaneously or with medication). 23 Patients were recruited to the protocol in a sequential, unselected manner. The protocol was run on an outpatient basis and co-ordinated by an asthma nurse specialist.
At the initial visit, a detailed semi-structured clinical history, which in part focussed on the presence of background psychosocial problems, was recorded on all subjects and full physical examination was performed. Based on the clinical history, the contribution of psychosocial factors after this assessment was graded by the assessing physician (LH in all cases) as 0 (not present), 1 (minor factor) and 2 (major factor). The evaluation protocol involved skin prick testing to 12 inhalant allergens, chest X-ray and spirometric testing with reversibility to nebulised b 2 -agonist, urinalysis, a standardised battery of blood tests and induced sputum, which were all performed at Visit 1. Asthma-related quality of life and HADS were completed at Visit 1. Asthma-related quality of life was assessed using the Juniper scale. 24 The response options for each of the 32 items are on a 7-point scale, ranging from 1 (totally limited) to 7 (not at all limited) and a clinically minimal significant change in overall score is 0.5. 25 Anxiety and depression scores were measured using the HADS. 21 The HADS defines a score of 0-7 as normal, 8-10 as being mildly disturbed and 11 or more as definite psychiatric caseness or subjects who require psychiatric assessment.
The following investigations were arranged as part of the investigative protocol: formal psychiatric interview, ear, nose and throat examination, pulmonary function testing (inspiratory/expiratory flow volume loop, carbon monoxide transfer factor and lung volumes by helium dilution), high-resolution CT scan of thorax, 24 h dual probe ambulatory oesophageal pH monitoring and dual emission X-ray absorptimetry (DEXA) scan. All subjects were offered the services of a social worker, if an underlying contributory social issue was identified either by the chest physician or after psychiatric evaluation. Any identified co-existent morbidity was managed using standard intervention and therapies as previously described. 22 Asthma was managed according to BTS Guidelines with treatment being stepped up and down as appropriate. 2 The lowest dose of inhaled corticosteroid required to control their asthma during the period of evaluation was recorded. Therapy-resistant asthma (TRA) was defined in accordance with the ERS Task Force on Difficult Asthma; specifically persisting symptoms due to asthma despite high-dose inhaled steroids (2000 mg beclomethasone, 1600 mg budesonide, 1000 mg fluticasone) plus long-acting beta-agonist with the requirement for either maintenance systemic steroids or at least 2 rescue courses of steroids during a follow-up period of 12 months and despite trials of other add-on therapies e.g. leukotriene receptor antagonist or theophylline. In subjects with non-therapy-resistant asthma, asthma-related quality of life and HAD were completed on discharge and in TRA, 12-18 months after protocol assessment.
Psychiatric evaluation
All patients were offered a formal psychiatric interview as part of their evaluation protocol. Psychiatric diagnoses were determined by a systematic clinical interview performed by experienced liaison psychiatrists (EC and CK) following the guidelines of the International Classification of Diseases (ICD10) of Mental and Behavioural disorders. The psychiatrists were aware that patients had difficult-to-control asthma but no other background clinical or demographic information prior to assessment. In cases where there was any uncertainty over clinical diagnosis a consensus was reached between EC and CK. After assignation of diagnosis, an individual treatment programme was designed. Referral was made to local psychiatric services, clinical psychology and/or social work services if appropriate or pharmacotherapy was initiated with GP and CPN involvement.
Statistical analysis
Demographic data are presented as mean7 standard error of the mean, or as the absolute value. Univariate analysis was performed using unpaired t-test for continuous variables, and Chisquare (w 2 ) analysis for dichotomous variables. All statistics were performed using SPSS for Windows Version 11.
Results
Over an 18-month recruitment period, 86 patients were referred to the service, and of these, 6 were omitted at Visit 1, because they did not fulfil our entry criteria at the time of first attendance (4 were not taking a long-acting beta-agonist despite its apparent prescription and 2 were no longer difficult to control). Of the remaining 80 subjects, 6 were lost to analysis (4 subjects were non-compliant with the protocol, 1 subject had oesophageal adenocarcinoma diagnosed during evaluation, 1 subject emigrated). In 1 further subject, a diagnosis of asthma could not be sustained after review of attendance and serial lung function.
Of the remaining 73 subjects, 34 were classified as TRA after evaluation. Of these 73 subjects, 8 (11%) subjects did not have a psychiatric assessment (4 refused assessment, 1 lost referral, 1 cognitive impairment (congenital), 1 already attending clinical psychology, 1 failed to attend), though none of the therapy-resistant group refused or failed to attend. The demographic details of the remaining 65 subjects are shown in Table 1 .
Psychiatric morbidity was common; 32 (49%) had an ICD10 psychiatric diagnosis and of these only 6 (9%) had been previously identified and were receiving current treatment. Subjects with a psychiatric illness were more likely to be current smokers (Table 1) . Depressive illness (F32) was the most common diagnosis (19 [59%] ) followed by generalised anxiety disorder (F41.1) (5 [16%] ). The other 8 subjects had a variety of conditions; posttraumatic stress disorder (F43.1), acute stress reaction (F43.0), specific phobia (F40.2), eating disorder (F50), organic affective disorder (F06.3), persistent delusional disorder (F22), anankastic personality disorder (F60.5) and mixed personality disorder (F60.9). There was no difference in the overall prevalence of psychiatric illness, undiagnosed psychiatric illness or depression in subjects with TRA compared to subjects who responded to systematic evaluation and management. (Table 2 ).
In subjects with undiagnosed psychiatric illness, specific management was defined at time of assessment. In subjects with depression, 8 were classed as having mild depressive illness, 9 had moderate depressive illness and 2 were classified as severe clinical depression. Subjects with depression were treated as clinically appropriate according to need, with either a selective serotonin reuptake inhibitor (SSRI) or a serotonin noradrenaline reuptake inhibitor (SNRI) and linked with psychiatric services as necessary. Subjects with anxiety and stress disorders were referred to clinical psychology service involving subsequent cognitive behavioural therapy and a stress management programme. The subject with persistent delusional disorder was commenced on Olanzapine and assessed urgently by psychiatric services. The subject with organic affective disorder was problematic in that she had steroid-dependent asthma but developed mild hypomania/aggression when on high-dose systemic steroids. She was managed by taking Chlorpromazine when she was on high-dose steroids. The subject with eating disorder had ongoing contact with psychotherapy services. The subject with mixed personality disorder engaged in analytic psychotherapy. The subject with anankastic personality disorder refused any form of support.
ARTICLE IN PRESS
When the respiratory physician (LH) scored 0 for psychiatric illness, 21 of 33 had no ICD10 psychiatric diagnosis but 12 did, when he graded 1, 11 out of 22 had a psychiatric diagnosis, when physician graded 2, 9 out of 10 had a psychiatric diagnosis (Table 2) .
Anxiety scores (13.470.8 vs. 8.570.7) and depression scores (10.270.7 vs. 4.870.5) scores with HADS were significantly higher in subjects with an ICD10 diagnosis (Po0:001). Defining a HAD score of 8 or above as abnormal, the positive predictive value (PPV) and negative predictive value (NPV) for all psychiatric illness were 59% and 86%, respectively, and for depressive illness PPV 44%, NPV 92%. Defining a HAD score of 11 or above as abnormal, the PPV and NPV for all psychiatric illness were 74% and 73%, respectively, and for depressive illness PPV 67%, NPV 89%.
Significant and clinically relevant improvements in asthma-related quality of life was noted in the group defined as responders supporting the clinical diagnosis of responsive asthma (Table 3) . This was not observed in the therapy-resistant group consistent with their disease-specific quality of life being unchanged despite extensive investigation and management of all identified provoking factors. Anxiety and depression scores were identical at presentation in both groups. At discharge/ follow-up, depression scores were significantly better in the therapy-resistant group (Po0:05; Table 3 ) but not in the responsive group.
Discussion
This study demonstrates a high prevalence (49%) of psychiatric morbidity in subjects referred with difficult-to-control asthma, with only 9% of having been previously recognised. Our most common diagnosis was depressive illness (29%), which is consistent with Mancuso and colleagues, who detected depressive symptoms in almost half of subjects with moderate asthma using a variety of screening tools. 26 Nascimento, using the MiniInternational Neuropsychiatric Interview (MINI) questionnaire, had depression rates of 33.7% and Brown using clinical interview with patients with moderate to severe disease found current depressive disorder of 25% which was again largely undiagnosed. 14, 27 Since depressive illness is common and has been associated with poor medication compliance, loss to follow-up 28 and asthma death, 5, 6 identification and treatment of depression is potentially important in this population.
There are limitations to the psychiatric assessment in this study, in that ICD10 diagnoses were not supported by research diagnostic interviews. This was a pragmatic study looking at the clinical psychiatric diagnosis in a hierarchical manner in this particular group of asthma patients. The goal of the psychiatric assessment was to assign the most severe primary psychiatric diagnosis, to which treatment could be directed and this is reported in this study. This represents a standard clinical approach to psychiatric assessment and treatment and an assessment strategy that can be reasonably delivered in this group of patients. We are unable to comment on the prevalence of psychiatric morbidity, assessed by psychiatric interview, in subjects with mild asthma as our study did not have such a control group, and we are unaware of any previous study, which has used psychiatric interview as the main assessment tool, in subjects with mild to moderate disease. Table 2 Distribution of ICD10 diagnoses and physician scores at presentation in all subjects and subjects with therapy-resistant asthma and non-therapy-resistant asthma after evaluation.
ARTICLE IN PRESS
All patients (n ¼ 65) Ã Clinical scores, relating to the presence of a psychological factor, were graded by the assessing physician on the basis of clinical history and graded 0 (not present), 1 (minor factor), 2 (major factor).
It may not always be possible for hospital difficult asthma services to have a psychiatrist present; therefore, it becomes important for us to include ways of detecting psychiatric morbidity that can be incorporated simply into respiratory clinics. When the chest physician was scoring the contribution of psychiatric illness to the difficult asthma, if he felt a psychiatric condition was a major contributing factor he was likely to be correct (9 out of 10 cases) but when he felt it was not present or a minor factor he was at least as likely to be wrong (23 from 55). This was despite a semi-structured clinical evaluation designed to detect psychosocial problems and administered by a focused respiratory physician and suggests that chest physicians are likely to miss significant underlying psychiatric illness.
Because of this, the use of screening tools may help the physician to detect morbidity and to refer for assessment. We used the Hospital Anxiety and Depression scale, which is a commonly used tool in hospital outpatient settings and determined negative and positive predictive values for detecting all morbidity and the commonest condition, depressive illness. The major problem in detecting all psychiatric illness using any abnormal score was the poor PPV i.e. false positives. Increasing the threshold score to 11 improved this to a degree but still resulted in a high false positive value. This observation questions the validity of studies using general psychological screening tools in isolation, and may explain some reported very high prevalence of psychiatric morbidity using such instruments. 13, 14, 20 Whilst there may be differences between different questionnaires, we would suggest that such screening questionnaires need validation in specific asthmatic populations, because many of the questions particularly with regard to anxiety symptoms may be interpreted and answered differently by subjects with asthma. The breadth of other psychiatric diagnoses in our series should also be noted which reached the level of psychosis in 2 cases. Single diagnosis screening instruments could potentially misidentify significant pathology. In addition, we chose to assign only one psychiatric diagnosis with depression ahead of anxiety in our ICD10 hierarchy, since depressive illness is often associated with anxiety symptoms and treating the depressive illness often causes resolution of these. This again highlights the discriminatory problems with screening questionnaires and supports using a formal psychiatric interview to diagnose specific psychiatric illness in this group.
The NPV for all psychiatric illness was better and suggests that an underlying psychiatric diagnosis is unlikely (though not excluded) when both anxiety and depression scores are normal. The depression score is particularly useful because if this is normal Table 3 Asthma Quality of Life and Anxiety and Depression Scores at presentation and discharge (therapyresponsive asthma) or follow-up (therapy-resistant asthma-12-18 months after referral), in all subjects and subjects with therapy-resistant asthma and non-therapy-resistant asthma after evaluation. 24 The response options for each of the 32 items are on a 7-point scale, ranging from 1 (totally limited) to 7 (not at all limited) and a clinically minimal significant change in overall score is 0.5 (Juniper et al. 25 ). y Anxiety and depression scores were measured using the Hospital Anxiety and Depression scale (Zigmond et al. 21 -scores are categorised as normal 0-7, mild 8-10, moderate 11-14, severe [15] [16] [17] [18] [19] [20] [21] . Data are presented as mean7standard error or absolute values unless stated otherwise. the chance of depressive illness (the commonest individual diagnosis) is minimal.
We also hypothesised that detection and treatment of psychiatric illness would be associated with improved asthma outcome. This is not supported by the observation of a similar prevalence of psychiatric illness in those whose asthma improved, compared to those who failed to respond to intervention and the lack of change in asthmarelated quality of life in the latter group despite psychiatric evaluation and treatment. In addition, in the group with the better asthma outcome, there was no change in their anxiety and depression scores, whilst in the therapy-resistant group, depression scores were significantly improved. Our findings suggest some dissociation between psychiatric and asthma outcome in this population, and suggest that the potential role of background psychopathology in difficult asthma is not a straightforward one. We appreciate that to fully examine the relationship between treatment of psychiatric disorder and asthma outcome, a randomised controlled trial would be required, but given the range of psychiatric diagnoses observed and the different therapeutic requirements, such a trial may be impractical. However, we still believe that, given the considerable prevalence of psychiatric disorder in this population, routine assessment and management of psychiatric morbidity should be performed.
In conclusion, undetected psychiatric illness is common in a group of sequentially referred difficult-to-control asthmatics, with depression being particularly prevalent. A simple screening questionnaire such as HADS has a high rate of false positives when compared to psychiatric interview, but may be useful in excluding depressive illness. There does not appear to be straightforward association between identification and management of co-existent psychiatry morbidity and improved asthma outcome in difficult asthma.
